
Asston Pharmaceuticals Limited IPO
Asston Pharmaceuticals Limited IPO is a SME book building IPO. Price band is ₹123 per share. Minimum investment is ₹2.46 L. Lot size is 1000 shares. Open from 9 Jul 2025 to 11 Jul 2025. Allotment on 14 Jul 2025. Listing on 16 Jul 2025 at BSE. Managed by Sobhagya Capital Options Ltd. Registrar: Maashitla Securities Private Limited. Key details for GMP, subscription, price, allotment, and listing in one place.
Asston Pharmaceuticals Limited IPO overview
Asston Pharmaceuticals Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Asston Pharmaceuticals Limited IPO important dates
Asston Pharmaceuticals Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,46,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,69,000 |
| S-HNI (UPI) | 4 | 4,000 | ₹4,92,000 |
| S-HNI (Max) | 8 | 8,000 | ₹9,84,000 |
| B-HNI (Min) | 9 | 9,000 | ₹11,07,000 |
About Asston Pharmaceuticals Limited IPO
From the company / RHP narrative.
The company offers a diverse range of products, including tablets, capsules, sachets, and syrups. Its product portfolio encompasses various therapeutic categories, such as analgesics, antibiotics, antifungals, vitamins, and more.
The company manufactures pharmaceutical products for direct sales and also on a contract manufacturing or loan license basis, primarily working on a principle-to-principle approach with various marketers.
The company is FDA certified by both Central and State FDA, accredited by NQA (Nuclear Quality Assurance), and complies with Quality Management System (QMS) standards, ensuring high-quality manufacturing.
Products:
Albendazole USP 400 mg: Albendazole USP 400 mg refers to a higher dosage of Albendazole, a broad-spectrum anthelmintic (anti-worm) medication that is used to treat various parasitic worm infections.
Diclofenac 100 mg: Diclofenac 100 mg refers to a specific dosage of Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID).
Ibuprofen, paracetamol: Ibuprofen and Paracetamol (Acetaminophen) are two commonly used over-the-counter medications, often used to relieve pain and reduce fever.
Ferrovit Syrup: To treat vitamin and mineral deficiencies.
As of 3 July 2025, the company has 46 Permanent employees and 6 contractual employees in various departments.
Competitive Strengths:
Formulation Expertise
Experienced Promoters
Wide range of Products
Strategic Location
Skilled Workforce
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding the incremental working capital requirements of the Company
Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company
General Corporate Purposes
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow IPO & unlisted research in the app, available on iOS and Android.